Because both are CNS stimulants with overlapping mechanisms, co-administration significantly elevates the risk of cardiovascular events, including dangerously elevated heart rate, high blood pressure, and arrhythmia
SAG via thioesterase hydrolysis) no metabolic competition
Dozens of patients are suing Eli Lilly and Novo Nordisk, the two companies that make GLP-1 drugs to treat diabetes and weight loss, claiming they suffered distressing digestive symptoms, such as gallbladder removal or gastroparesis, after taking the medication
Wound healing models: All three peptides have demonstrated accelerated wound closure in excisional, incisional, and burn models in published preclinical literature
Control medium samples were generated by incubating the treatment medium in cell-free 6-well plates under the same conditions and duration as the cell culture samples
PlexusDx recommends evaluating your dietary adherence, confirming your injection technique is correct, and discussing dose escalation with your clinician